Ads
related to: new treatments for dementia- Alzheimer's Disease Info
Learn About the Stages of AD &
Diagnostic Tests for Patients.
- Getting Started
Read Infusion FAQs & Tips For
Getting Started With Treatment.
- For Care Partners
Help Support Your Loved One. See
Helpful Tips & Resources.
- Support & Resources
Access Downloadable Patient
Resources Available On-Site.
- Alzheimer's Disease Info
Search results
Results From The WOW.Com Content Network
After 670 days, there were 1,172 new diagnoses of dementia among the study participants. When compared with people who took DPP-4 inhibitors, those who took SGLT-2 inhibitors had a 35 percent ...
Credit - Getty Images. 2023 was a strong year for innovative new drugs, with new medications for Alzheimer’s disease, weight loss, and the first treatment based on the gene-editing technology ...
“Now, we have FDA-approved treatments and ways to reduce dementia risk that could make a difference,” says Dr. Kaiser. Keep reading for Dr. Kaiser’s and Dr. Ertekin-Taner’s top tips for ...
Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...
Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. [2] [4] Lecanemab is an amyloid beta-directed antibody. [2] It is given via intravenous infusion to patients with mild cognitive impairment or mild dementia. [2]
The analysis showed that over a follow-up period of an average of 2.06 years for people on SGLT2 inhibitors, and 3.70 years for people on different antidiabetes drugs, there was a reduction in the ...